Mike Harsh Addresses Investors in Sydney, Australia

Nov 21, 2019
Posted in: News

Home » Mike Harsh Addresses Investors in Sydney, Australia

Mike Harsh Addresses Investors in Sydney, Australia

Nov 21, 2019
Posted in: News

Non-Executive Director Mike Harsh addresses Imagion Biosystems’ investors. November, 2019.

Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study

August 21, 2025

Earlier this month, our own Bob Proulx, Executive Chairman of Imagion Biosystems, had the opportunity to join Stuart Roberts on Pitt Street Research’s podcast Stocks

Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics

August 13, 2025

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging

Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer

February 19, 2025

MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Mike Harsh Addresses Investors in Sydney, Australia

Mike Harsh Addresses Investors in Sydney, Australia

Related Articles

Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study

Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics

Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list